Adverse neurologic events of immune checkpoint inhibitor monotherapy vs. combination therapy for melanoma
Neurooncol Adv. 2025 Feb 7;7(1):vdaf030. doi: 10.1093/noajnl/vdaf030. eCollection 2025 Jan-Dec. ABSTRACT BACKGROUND: Over the past decade, novel immune checkpoint inhibitors have revolutionized melanoma treatment. These …